DNB Asset Management AS bought a new stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 154,404 shares of the company's stock, valued at approximately $2,066,000.
Several other institutional investors and hedge funds have also bought and sold shares of PATH. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of UiPath during the 2nd quarter valued at $28,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in UiPath during the 2nd quarter valued at about $55,000. Covestor Ltd raised its stake in UiPath by 17.7% in the third quarter. Covestor Ltd now owns 6,522 shares of the company's stock valued at $87,000 after buying an additional 981 shares during the last quarter. CX Institutional boosted its holdings in UiPath by 37.4% in the third quarter. CX Institutional now owns 6,888 shares of the company's stock worth $92,000 after acquiring an additional 1,874 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB grew its stake in shares of UiPath by 507.0% during the third quarter. Wilmington Savings Fund Society FSB now owns 7,502 shares of the company's stock worth $100,000 after acquiring an additional 6,266 shares during the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at UiPath
In related news, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction dated Monday, January 26th. The stock was sold at an average price of $15.01, for a total transaction of $675,450.00. Following the sale, the chief executive officer directly owned 27,893,585 shares of the company's stock, valued at $418,682,710.85. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ashim Gupta sold 67,468 shares of UiPath stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $16.10, for a total value of $1,086,234.80. Following the transaction, the chief financial officer owned 557,028 shares of the company's stock, valued at approximately $8,968,150.80. This represents a 10.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 950,048 shares of company stock worth $15,881,744 in the last 90 days. Company insiders own 23.19% of the company's stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Barclays increased their price objective on shares of UiPath from $16.00 to $18.00 and gave the company an "equal weight" rating in a research report on Monday, January 12th. BMO Capital Markets raised their price target on shares of UiPath from $13.00 to $17.00 and gave the stock a "market perform" rating in a report on Thursday, December 4th. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Thursday, December 4th. DA Davidson upped their target price on UiPath from $12.00 to $15.00 and gave the company a "neutral" rating in a research report on Thursday, December 4th. Finally, Royal Bank Of Canada set a $14.00 target price on UiPath in a research note on Wednesday, February 11th. One analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $15.77.
Get Our Latest Stock Report on PATH
UiPath Price Performance
Shares of UiPath stock opened at $11.06 on Wednesday. The stock has a market cap of $5.91 billion, a PE ratio of 26.33, a price-to-earnings-growth ratio of 1.46 and a beta of 1.09. The firm has a fifty day moving average price of $13.77 and a 200 day moving average price of $13.98. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $19.84.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.02. The company had revenue of $411.11 million for the quarter, compared to the consensus estimate of $392.46 million. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The firm's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the firm earned $0.11 EPS. As a group, equities analysts expect that UiPath, Inc. will post -0.17 EPS for the current year.
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.